Discontinuation report TIGECYCLINE
Report ID | 87218 |
Drug Identification Number | 02409356 |
Brand name | TIGECYCLINE |
Common or Proper name | TIGECYCLINE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | TIGECYCLINE |
Strength(s) | 50MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 5ML VIAL |
ATC code | J01AA |
ATC description | TETRACYCLINES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2020-01-01 |
Actual discontinuation date | |
Remaining supply date | 2020-01-01 |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Limited inventory is availble |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2019-06-21 | French | Compare |
v1 | 2019-06-21 | English | Compare |
Showing 1 to 2 of 2